Cargando…

Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells

Dendritic cell (DC)-based cancer immunotherapy requires an immunogenic tumor-associated antigen and an effective therapeutic strategy. Glypican 3 (GPC3) is a valuable diagnostic marker and a potential therapeutic target in hepatocellular carcinoma (HCC). The present study investigated whether DCs tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	WANG, YULIANG, WANG, YINLONG, MU, HONG, LIU, TAO, CHEN, XIAOBO, SHEN, ZHONGYANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368068/ https://www.ncbi.nlm.nih.gov/pubmed/25625609 http://dx.doi.org/10.3892/mmr.2015.3239

Ejemplares similares

Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
por: Cao, Jing, et al.
Publicado: (2019)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
por: Liu, Yan, et al.
Publicado: (2017)

Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma
por: Yang, Chan-Keng, et al.
Publicado: (2023)

Cytokine-induced killer cells promote antitumor immunity
por: Jiang, Jingting, et al.
Publicado: (2013)

Cytokine-induced killer cells co-cultured with dendritic cells loaded with the protein lysate produced by radiofrequency ablation induce a specific antitumor response
por: SHAN, CHAN-CHAN, et al.
Publicado: (2015)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis
por: Yuan, Xin, et al.
Publicado: (2021)

Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
por: Du, Hansong, et al.
Publicado: (2020)

Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells
por: Wang, Zhu, et al.
Publicado: (2020)

NaHCO(3) enhances the antitumor activities of cytokine-induced killer cells against hepatocellular carcinoma HepG2 cells
por: Yuan, Ya Hong, et al.
Publicado: (2016)

Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2017)

Targeting regulatory T cells in cytokine-induced killer cell cultures (Review)
por: TAO, QIANSHAN, et al.
Publicado: (2014)

Cytokine-induced killer cell/dendritic cell–cytokine-induced killer cell immunotherapy for the postoperative treatment of gastric cancer: A systematic review and meta-analysis
por: Wang, Xiang, et al.
Publicado: (2018)

Dendritic Cell Derived Cytokines in Human Natural Killer Cell Differentiation and Activation
por: Chijioke, Obinna, et al.
Publicado: (2013)

One Single Site Clinical Study: To Evaluate the Safety and Efficacy of Immunotherapy With Autologous Dendritic Cells, Cytokine-Induced Killer Cells in Primary Hepatocellular Carcinoma Patients
por: Xu, Kaiyue, et al.
Publicado: (2020)

Correction: Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2018)

Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients
por: Zhang, Lei, et al.
Publicado: (2017)

Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system
por: Yang, Tao, et al.
Publicado: (2018)

Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy
por: Garofano, Francesca, et al.
Publicado: (2019)

Generation of functional CD8+ T Cells by human dendritic cells expressing glypican-3 epitopes
por: O'Beirne, James, et al.
Publicado: (2010)

Curative Effects of Dendritic Cells Combined with Cytokine-Induced Killer Cells in Patients with Malignant Pericardial Effusion
por: Wang, Hongmin, et al.
Publicado: (2016)

Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus
por: GONG, HAN-XIAN, et al.
Publicado: (2011)

Autologous adipose tissue-derived mesenchymal stem cells are involved in rat liver regeneration following repeat partial hepatectomy
por: LIU, TAO, et al.
Publicado: (2016)

Distinct Cytokine Profiles of Neonatal Natural Killer T Cells after Expansion with Subsets of Dendritic Cells
por: Kadowaki, Norimitsu, et al.
Publicado: (2001)

T-Bet Mediated Anti-Neoplastic Effects of Dendritic Cell-Cytokine Induced Killer Cells in vitro
por: Miao, Liu, et al.
Publicado: (2012)

Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release
por: Liu, Xuan, et al.
Publicado: (2020)

Increase of Antitumoral Effects of Cytokine-Induced Killer Cells by Antibody-Mediated Inhibition of MICA Shedding
por: Wu, Xiaolong, et al.
Publicado: (2020)

Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety
por: Ma, Yue, et al.
Publicado: (2012)

Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor
por: Hjorton, Karin, et al.
Publicado: (2018)

Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells
por: Dhodapkar, Kavita M., et al.
Publicado: (2002)

Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas
por: El-Saadany, Sherif, et al.
Publicado: (2018)

Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
por: Nishida, Takahiro, et al.
Publicado: (2019)

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
por: Nakashima, Hiroyuki, et al.
Publicado: (2023)

Dendritic cells transduced with TIPE-2 recombinant adenovirus induces T cells suppression
por: Liu, Shudong, et al.
Publicado: (2021)

Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer
por: Wang, Danhong, et al.
Publicado: (2014)

Chemotherapy combined with dendritic cell vaccine and cytokine-induced killer cells in the treatment of colorectal carcinoma: a meta-analysis
por: Zhou, Xiuling, et al.
Publicado: (2018)

Antitumor Responses of Invariant Natural Killer T Cells
por: Altman, Jennie B., et al.
Publicado: (2015)

Cytokine-induced killer cells are type II natural killer T cells
por: Gütgemann, Stefan, et al.
Publicado: (2007)

P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma
por: Dargel, C, et al.
Publicado: (2014)

A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma
por: Pang, Ye-Bin, et al.
Publicado: (2019)

The Therapeutic Effect of Cytokine-Induced Killer Cells on Pancreatic Cancer Enhanced by Dendritic Cells Pulsed with K-Ras Mutant Peptide
por: Tan, Guang, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_da3grrf3c7i3n3sucda5qpibre